Cancer Home > Alemtuzumab
Alemtuzumab is a drug approved to treat a specific kind of leukemia called B-cell chronic lymphocytic leukemia. It works by signaling the immune system to bind to a certain type of antigen in white blood cells, which causes the cancer cells to die. A healthcare provider administers this product via infusion in a healthcare setting. Infections, fever, and chills are among the reported side effects.
What Is Alemtuzumab?Alemtuzumab (Campath®) is a prescription medication approved to treat a certain type of leukemia (cancer of the blood and bone marrow) known as B-cell chronic lymphocytic leukemia. It belongs to a group of drugs known as monoclonal antibodies.
Side Effects of AlemtuzumabJust like any medicine, alemtuzumab can cause side effects, some of which can be quite significant. In fact, most people who use the drug will experience some type of adverse reaction during treatment.
- Decreased blood cell counts